SUM159PT Cells
















General information
Description | The SUM159PT cell line is derived from an anaplastic carcinoma of the breast and is a model for triple-negative breast cancer (TNBC), a subtype lacking estrogen receptor (ER), progesterone receptor (PR), and HER2 expression. SUM159PT is characterized by its aggressive phenotype, anchorage-independent growth, and invasive potential, making it particularly valuable for studying TNBC biology and therapy. Genetic analysis of SUM159PT has revealed notable amplifications and deletions common in aggressive breast cancers. These include amplifications at chromosomal loci such as 8q (containing MYC) and losses at 8p, which are implicated in tumor progression. The line is aneuploid, consistent with many cancer cell lines, and shows alterations in pathways critical to proliferation and apoptosis. SUM159PT also exhibits basal-like features and expresses cytokeratins 5/6 and 14, markers associated with basal-type breast cancers. These characteristics reinforce its utility in modeling basal-like TNBC and exploring novel therapeutic approaches. Sensitivity studies on SUM159PT have highlighted its response to BET bromodomain inhibitors such as JQ1, which target epigenetic regulators like BRD4. Treatment with JQ1 induces significant morphological changes, including senescence and basal-to-luminal differentiation, while inhibiting proliferation and promoting apoptosis. These effects underscore the role of transcriptional control in TNBC survival and suggest potential for combination therapies targeting epigenetic regulators in resistant TNBC subtypes. This cell line is extensively used in both in vitro assays and in vivo xenograft models to evaluate the efficacy of new treatments. |
---|---|
Organism | Human |
Tissue | Breast |
Disease | Breast pleomorphic carcinoma |
Synonyms | SUM-159-PT, SUM-159PT, SUM 159PT, SUM-159, SUM 159, SUM159, 159 PT, 159PT |
Characteristics
Age | 71 years |
---|---|
Gender | Female |
Morphology | Epithelial |
Growth properties | Adherent |
Identifiers / Biosafety / Citation
Citation | SUM159PT (Cytion catalog number 305116) |
---|---|
Biosafety level | 1 |
Expression / Mutation
Handling
Culture Medium | Ham's F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a) |
---|---|
Medium supplements | Supplement the medium with 10% FBS, hydrocortisone, insulin |
Passaging solution | Accutase |
Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
Split ratio | 1:2 to 1:5 |
Fluid renewal | 2 to 3 times per week |
Freeze medium | As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
Handling of cryopreserved cultures |
|
Quality control / Genetic profile / HLA
Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
---|
Certificate of Analysis (CoA)
Lot Number | Certificate Type | Date | Catalog Number |
---|---|---|---|
305116-280923 | Certificate of Analysis | 15. Apr. 2025 | 305116 |